Delhi govt Update : imposes night curbs for today, tomorrow to restrict New

Eish Singhal, deputy commissioner of police (New Delhi), under whose jurisdiction Connaught Place, India Gate and Delhi Zoo are, said that a police meeting on implementing the ‘night curfew’ order is scheduled for later in the day. “Since the order was passed only on Wednesday night, we’ll have to decide how to implement it. We will be able to share details of the implementation plan only after the meeting,” said Singhal, who is also the Delhi Police spokesperson.

Also Read: WHO, marking year since Covid-19 began, urges fair vaccine distribution to all

“The ministry of home affairs through its order dated December 28 has advised states and union territories (that) based on their assessment of the https://www.pexels.com/@mp3-alice-cooper-detroit-stories-album-download-15612521 situation they may impose local restrictions, with a view to contain the spread of Covid-19, such as night curfew,” said the DDMA order.

It said, “A detailed assessment of the situation in Delhi has been made and considering the threat posed by the mutant UK strain of Covid-19 virus and after observing local incidents of Covid-19 pandemics in Delhi, it is apprehended that gatherings, congregations and public celebrations in New Year pose a considerable threat of spread of the virus.”

The order, however, wouldn’t apply inside premises of hotels, restaurants, pubs, etc. “In such premises, Covid-19 guidelines like a limit on number of persons, mandatory wearing of masks and ensuring other Covid-19 appropriate behaviour will apply,” said Dev.

It will not apply to private places either, he said, adding that people are advised not to host large gatherings.

In recent years, public spaces such as India Gate or Delhi zoo have reported gathering of tens of thousands on New Years’ Day.

New Delhi: The approval for a Covid vaccine can come  https://issuu.com/alicecooperdetroitstoriesalbumdownload soon, the country's drugs control authority has indicated. At a webinar today, Drugs Controller General Dr VG Somani said, "Probably we will have a happy New Year with something in hand. That is what I can hint at". The assurance from the Drugs Controller General came ahead of a crucial meeting of the expert panel on emergency use vaccine authorization, which is set for tomorrow.
Earlier today, Prime Minister Narendra Modi said "Preparations are in last stages for the vaccination programme against COVID-19. People will get vaccine manufactured in India".

This week, the government-appointed panel has taken up applications for the emergency use approval of vaccines manufactured by the Serum Institute of India, Bharat Biotech and Pfizer.

Serum Institute is making 'Covishield' developed by Oxford University and Pharma major AstraZeneca. Bharat Biotech has partnered the Indian Council of Medical https://www.uplabs.com/alicecooperdetroitstoriesfullalbumdownload Research (ICMR) for its 'Covaxin'. Both firms have made presentations before the panel.

The Serum Institute, which is manufacturing the vaccine, has assured that a majority of the first 50 million doses will go to India.

Comments "At least for the first month, most of our doses will go to India. We have a deal with other COVAX countries, but for exporting we will need approvals from World Health Organisation and licenses. So, India will receive first," company chief Adar Poonawalla has said.

control authority has indicated. At a webinar today, Drugs Controller General Dr VG Somani said, "Probably we will have a happy New Year with something in hand. That is what I can hint at". The assurance from the Drugs Controller General came ahead of a crucial meeting of the expert panel on https://expo.io/@alicecooperdetroitstoriesalbumdownload/ emergency use vaccine authorization, which is set for tomorrow.
Earlier today, Prime Minister Narendra Modi said "Preparations are in last stages for the vaccination programme against COVID-19. People will get vaccine manufactured in India".

This week, the government-appointed panel has taken up applications for the emergency use approval of vaccines manufactured by the Serum Institute of India, Bharat Biotech and Pfizer.